United States Pneumococcal Vaccines Market Report 2017

October 2017 | 120 pages | ID: U9BF5C0C6E9EN
QYResearch

Abstracts

In this report, the United States Pneumococcal Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Pneumococcal Vaccines in these regions, from 2012 to 2022 (forecast).

United States Pneumococcal Vaccines market competition by top manufacturers/players, with Pneumococcal Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Sanofi
• GSK
• Merck
• Eli Lilly
• AstraZeneca
• Abera
• S K Chemicals
• Beijing Minhai Biotechnology
• Baxter
• Biken
• Celgene Corporation
• Panacea Biotec
• Serum Institute of India
• Genentech
• Genocea Biosciences
• ImmunoBiology
• Lupin
• Nuron Biotech
• Biogen
• Valneva Austria
• Sinovac

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• PPSV 23
• PCV 7/13
• PCV 10

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• For Infants
• For Children (2-10)
• For Person (10-64)
• For The Old (≥65)

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Pneumococcal Vaccines Market Report 2017

1 PNEUMOCOCCAL VACCINES OVERVIEW

1.1 Product Overview and Scope of Pneumococcal Vaccines
1.2 Classification of Pneumococcal Vaccines by Product Category
  1.2.1 United States Pneumococcal Vaccines Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Pneumococcal Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 PPSV
  1.2.4 PCV 7/13
  1.2.5 PCV
1.3 United States Pneumococcal Vaccines Market by Application/End Users
  1.3.1 United States Pneumococcal Vaccines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 For Infants
  1.3.3 For Children (2-10)
  1.3.4 For Person (10-64)
  1.3.5 For The Old (≥65)
1.4 United States Pneumococcal Vaccines Market by Region
  1.4.1 United States Pneumococcal Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Pneumococcal Vaccines Status and Prospect (2012-2022)
  1.4.3 Southwest Pneumococcal Vaccines Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Pneumococcal Vaccines Status and Prospect (2012-2022)
  1.4.5 New England Pneumococcal Vaccines Status and Prospect (2012-2022)
  1.4.6 The South Pneumococcal Vaccines Status and Prospect (2012-2022)
  1.4.7 The Midwest Pneumococcal Vaccines Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Pneumococcal Vaccines (2012-2022)
  1.5.1 United States Pneumococcal Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 United States Pneumococcal Vaccines Revenue and Growth Rate (2012-2022)

2 UNITED STATES PNEUMOCOCCAL VACCINES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Pneumococcal Vaccines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Pneumococcal Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Pneumococcal Vaccines Average Price by Players/Suppliers (2012-2017)
2.4 United States Pneumococcal Vaccines Market Competitive Situation and Trends
  2.4.1 United States Pneumococcal Vaccines Market Concentration Rate
  2.4.2 United States Pneumococcal Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Pneumococcal Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PNEUMOCOCCAL VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Pneumococcal Vaccines Sales and Market Share by Region (2012-2017)
3.2 United States Pneumococcal Vaccines Revenue and Market Share by Region (2012-2017)
3.3 United States Pneumococcal Vaccines Price by Region (2012-2017)

4 UNITED STATES PNEUMOCOCCAL VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Pneumococcal Vaccines Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Pneumococcal Vaccines Revenue and Market Share by Type (2012-2017)
4.3 United States Pneumococcal Vaccines Price by Type (2012-2017)
4.4 United States Pneumococcal Vaccines Sales Growth Rate by Type (2012-2017)

5 UNITED STATES PNEUMOCOCCAL VACCINES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Pneumococcal Vaccines Sales and Market Share by Application (2012-2017)
5.2 United States Pneumococcal Vaccines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES PNEUMOCOCCAL VACCINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Pneumococcal Vaccines Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sanofi
  6.2.2 Pneumococcal Vaccines Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofi Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GSK
  6.3.2 Pneumococcal Vaccines Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GSK Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Merck
  6.4.2 Pneumococcal Vaccines Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merck Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Eli Lilly
  6.5.2 Pneumococcal Vaccines Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Eli Lilly Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 AstraZeneca
  6.6.2 Pneumococcal Vaccines Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 AstraZeneca Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Abera
  6.7.2 Pneumococcal Vaccines Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Abera Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 S K Chemicals
  6.8.2 Pneumococcal Vaccines Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 S K Chemicals Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Beijing Minhai Biotechnology
  6.9.2 Pneumococcal Vaccines Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Beijing Minhai Biotechnology Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Baxter
  6.10.2 Pneumococcal Vaccines Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Baxter Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Biken
6.12 Celgene Corporation
6.13 Panacea Biotec
6.14 Serum Institute of India
6.15 Genentech
6.16 Genocea Biosciences
6.17 ImmunoBiology
6.18 Lupin
6.19 Nuron Biotech
6.20 Biogen
6.21 Valneva Austria
6.22 Sinovac

7 PNEUMOCOCCAL VACCINES MANUFACTURING COST ANALYSIS

7.1 Pneumococcal Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pneumococcal Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Pneumococcal Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pneumococcal Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PNEUMOCOCCAL VACCINES MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Pneumococcal Vaccines Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Pneumococcal Vaccines Sales Volume Forecast by Type (2017-2022)
11.3 United States Pneumococcal Vaccines Sales Volume Forecast by Application (2017-2022)
11.4 United States Pneumococcal Vaccines Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Pneumococcal Vaccines
Figure United States Pneumococcal Vaccines Market Size (K Units) by Type (2012-2022)
Figure United States Pneumococcal Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure PPSV 23 Product Picture
Figure PCV 7/13 Product Picture
Figure PCV 10 Product Picture
Figure United States Pneumococcal Vaccines Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Pneumococcal Vaccines by Application in 2016
Figure For Infants Examples
Table Key Downstream Customer in For Infants
Figure For Children (2-10) Examples
Table Key Downstream Customer in For Children (2-10)
Figure For Person (10-64) Examples
Table Key Downstream Customer in For Person (10-64)
Figure For The Old (≥65) Examples
Table Key Downstream Customer in For The Old (≥65)
Figure United States Pneumococcal Vaccines Market Size (Million USD) by Region (2012-2022)
Figure The West Pneumococcal Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Pneumococcal Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Pneumococcal Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Pneumococcal Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Pneumococcal Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Pneumococcal Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2022)
Figure United States Pneumococcal Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Pneumococcal Vaccines Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Pneumococcal Vaccines Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Pneumococcal Vaccines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Pneumococcal Vaccines Sales Share by Players/Suppliers
Figure 2017 United States Pneumococcal Vaccines Sales Share by Players/Suppliers
Figure United States Pneumococcal Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Pneumococcal Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Pneumococcal Vaccines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Pneumococcal Vaccines Revenue Share by Players/Suppliers
Figure 2017 United States Pneumococcal Vaccines Revenue Share by Players/Suppliers
Table United States Market Pneumococcal Vaccines Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Pneumococcal Vaccines Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Pneumococcal Vaccines Market Share of Top 3 Players/Suppliers
Figure United States Pneumococcal Vaccines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Pneumococcal Vaccines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Pneumococcal Vaccines Product Category
Table United States Pneumococcal Vaccines Sales (K Units) by Region (2012-2017)
Table United States Pneumococcal Vaccines Sales Share by Region (2012-2017)
Figure United States Pneumococcal Vaccines Sales Share by Region (2012-2017)
Figure United States Pneumococcal Vaccines Sales Market Share by Region in 2016
Table United States Pneumococcal Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Pneumococcal Vaccines Revenue Share by Region (2012-2017)
Figure United States Pneumococcal Vaccines Revenue Market Share by Region (2012-2017)
Figure United States Pneumococcal Vaccines Revenue Market Share by Region in 2016
Table United States Pneumococcal Vaccines Price (USD/Unit) by Region (2012-2017)
Table United States Pneumococcal Vaccines Sales (K Units) by Type (2012-2017)
Table United States Pneumococcal Vaccines Sales Share by Type (2012-2017)
Figure United States Pneumococcal Vaccines Sales Share by Type (2012-2017)
Figure United States Pneumococcal Vaccines Sales Market Share by Type in 2016
Table United States Pneumococcal Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Pneumococcal Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pneumococcal Vaccines by Type (2012-2017)
Figure Revenue Market Share of Pneumococcal Vaccines by Type in 2016
Table United States Pneumococcal Vaccines Price (USD/Unit) by Types (2012-2017)
Figure United States Pneumococcal Vaccines Sales Growth Rate by Type (2012-2017)
Table United States Pneumococcal Vaccines Sales (K Units) by Application (2012-2017)
Table United States Pneumococcal Vaccines Sales Market Share by Application (2012-2017)
Figure United States Pneumococcal Vaccines Sales Market Share by Application (2012-2017)
Figure United States Pneumococcal Vaccines Sales Market Share by Application in 2016
Table United States Pneumococcal Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States Pneumococcal Vaccines Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Pneumococcal Vaccines Sales Growth Rate (2012-2017)
Figure Pfizer Pneumococcal Vaccines Sales Market Share in United States (2012-2017)
Figure Pfizer Pneumococcal Vaccines Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Pneumococcal Vaccines Sales Growth Rate (2012-2017)
Figure Sanofi Pneumococcal Vaccines Sales Market Share in United States (2012-2017)
Figure Sanofi Pneumococcal Vaccines Revenue Market Share in United States (2012-2017)
Table GSK Basic Information List
Table GSK Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Pneumococcal Vaccines Sales Growth Rate (2012-2017)
Figure GSK Pneumococcal Vaccines Sales Market Share in United States (2012-2017)
Figure GSK Pneumococcal Vaccines Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Pneumococcal Vaccines Sales Growth Rate (2012-2017)
Figure Merck Pneumococcal Vaccines Sales Market Share in United States (2012-2017)
Figure Merck Pneumococcal Vaccines Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Pneumococcal Vaccines Sales Growth Rate (2012-2017)
Figure Eli Lilly Pneumococcal Vaccines Sales Market Share in United States (2012-2017)
Figure Eli Lilly Pneumococcal Vaccines Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Pneumococcal Vaccines Sales Growth Rate (2012-2017)
Figure AstraZeneca Pneumococcal Vaccines Sales Market Share in United States (2012-2017)
Figure AstraZeneca Pneumococcal Vaccines Revenue Market Share in United States (2012-2017)
Table Abera Basic Information List
Table Abera Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abera Pneumococcal Vaccines Sales Growth Rate (2012-2017)
Figure Abera Pneumococcal Vaccines Sales Market Share in United States (2012-2017)
Figure Abera Pneumococcal Vaccines Revenue Market Share in United States (2012-2017)
Table S K Chemicals Basic Information List
Table S K Chemicals Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure S K Chemicals Pneumococcal Vaccines Sales Growth Rate (2012-2017)
Figure S K Chemicals Pneumococcal Vaccines Sales Market Share in United States (2012-2017)
Figure S K Chemicals Pneumococcal Vaccines Revenue Market Share in United States (2012-2017)
Table Beijing Minhai Biotechnology Basic Information List
Table Beijing Minhai Biotechnology Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Beijing Minhai Biotechnology Pneumococcal Vaccines Sales Growth Rate (2012-2017)
Figure Beijing Minhai Biotechnology Pneumococcal Vaccines Sales Market Share in United States (2012-2017)
Figure Beijing Minhai Biotechnology Pneumococcal Vaccines Revenue Market Share in United States (2012-2017)
Table Baxter Basic Information List
Table Baxter Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Baxter Pneumococcal Vaccines Sales Growth Rate (2012-2017)
Figure Baxter Pneumococcal Vaccines Sales Market Share in United States (2012-2017)
Figure Baxter Pneumococcal Vaccines Revenue Market Share in United States (2012-2017)
Table Biken Basic Information List
Table Celgene Corporation Basic Information List
Table Panacea Biotec Basic Information List
Table Serum Institute of India Basic Information List
Table Genentech Basic Information List
Table Genocea Biosciences Basic Information List
Table ImmunoBiology Basic Information List
Table Lupin Basic Information List
Table Nuron Biotech Basic Information List
Table Biogen Basic Information List
Table Valneva Austria Basic Information List
Table Sinovac Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pneumococcal Vaccines
Figure Manufacturing Process Analysis of Pneumococcal Vaccines
Figure Pneumococcal Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Pneumococcal Vaccines Major Players/Suppliers in 2016
Table Major Buyers of Pneumococcal Vaccines
Table Distributors/Traders List
Figure United States Pneumococcal Vaccines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Pneumococcal Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Pneumococcal Vaccines Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Pneumococcal Vaccines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Pneumococcal Vaccines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Pneumococcal Vaccines Sales Volume (K Units) Forecast by Type in 2022
Table United States Pneumococcal Vaccines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Pneumococcal Vaccines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Pneumococcal Vaccines Sales Volume (K Units) Forecast by Application in 2022
Table United States Pneumococcal Vaccines Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Pneumococcal Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Pneumococcal Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Pneumococcal Vaccines Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources